A novel digital health device
DeviceA videogame-generated virtual world designed for the AD/ADRD care dyad.
Other names: DevaWorld
NCT Number: NCT05418296
This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.
Looking for future studies?
Notify MeUp to 110 year
All sexes
Interventional
Not applicable
Bruceville Point Senior Living Community, Elk Grove, California, United States
Central themes in person-centered care are dignity/respect/choice for the care recipient.
This Phase l clinical study is a minimal risk study that focuses on how the new technology can support and amplify these principles, while assisting care staff.
The investigators will use a novel digital health device developed with user-centered design principles, mirroring a range of evidence-based non-pharmacological interventions for people living with Alzheimer's disease and its related dementias (AD/ADRD). This is a purpose-built virtual world depicting activities of daily living (ADLs). It contains interactive engagement stimuli, including customized digital artifacts that hold meaning to the person.
The investigators hypothesize that undertaking ADL-related virtual activities will support completions of actual ADLs, thereby increasing effectiveness and improving care outcomes.
Aim 1: Feasibility Successful outcomes are >55% participation rate and a statistically significant difference between assessments of participation and non-participation, indicating tolerability and acceptability of routine interventions.
Aim 2: Effectiveness
Successful outcomes are:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The subject will have a diagnosis of AD/ADRD, or symptoms of an undiagnosed AD/ADRD as observed by professional care staff and confirmed by the head of clinical care. The investigators will neither include nor exclude participation based on cognitive test scores. The subject will have had challenge(s) completing one or more ADLs in the previous month, as discussed at staff meetings, referenced in care plans, or observed/experienced by direct care staff.
Other specifications:
Exclusion criteria
Ineligible subjects are those with significant non-AD/ADRD neurological, psychiatric, or physical impairment or those who are totally dependent upon others for ADLs.
A videogame-generated virtual world designed for the AD/ADRD care dyad.
Other names: DevaWorld
Time frame: 6 weeks
The ADCS-ADL assesses the competence of patients with Alzheimer's Disease (AD) in basic and instrumental activities of daily living (ADLs). It can be completed by a caregiver in questionnaire format, or administered by a clinician/researcher as a structured interview with a caregiver.
There are 19 questions. The minimum and maximum values are 0 - 54. A higher score means a better outcome.
Time frame: 6 weeks
The NPI-NH The NPI-NH has been used to characterize the psychopathology of patients in nursing homes as well as to measure the impact of anti dementia and psychotropic drugs and behavioral changes in dementia patients dwelling in nursing homes.
There are questions. The minimum and maximum values are 12 - 120 A lower score means a better outcome.
Time frame: 6 weeks
The ADQ is a validated questionnaire that aims to assess participants' attitudes towards dementia, and has been shown to be reliable, easy to administer and to score. The ADQ is a 19-item survey that assesses attitudes towards people living with dementia using a five-point Likert scale ranging from 'strongly agree' to 'strongly disagree'.
The total ADQ score ranges from 19 to 95, with higher scores reflecting more positive attitudes towards people living with dementia.
Time frame: 6 weeks
The SCIDS scale provides a useful and user-friendly means of measuring sense of competence in care staff.
There are questions. The minimum and maximum values are 17 - 68 A higher score means a better outcome.
Time frame: 6 weeks
The Copenhagen Burnout Inventory (CBI) is a 19-item survey that measures burnout in three areas: personal, work-related, and client-related.
Scale ranges from 0 to 300, with high scores indicating high levels of burnout. This inventory is self-administered
mandy
Industry
Assessing a Novel Virtual Environment That Primes Individuals Living With AD/ADRD to Accomplish Activities of Daily Living
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05202223
Alzheimer Disease, Behavior
Lexington, Kentucky, United States
View Trial DetailsNCT05318976
Alzheimer Disease, Brain Diseases
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT05080777
Alzheimer Disease, Brain Diseases
Farmington, Connecticut, United States
View Trial DetailsNCT05527288
Alzheimer Disease, Brain Diseases
Beijing, Beijing Municipality, China
View Trial Details